Long COVID Diagnostic Reactivity Assesment Test (EAV-LONGCOVID)

Oncology Center,Ministry Of Heath,Uzbekistan

Status: Invitation-only

Conditions: Long COVID; Post-Acute Sequelae of SARS-CoV-2 Infection

Treatments: Diagnostic Test: Electrodiagnostic Bioelectrical Assessment

Study type: Interventional

Funder types: Other

Identifiers

NCT07343856

9/36-2216

Details and patient eligibility

About

This study is a diagnostic clinical investigation designed to evaluate bioelectrical response patterns assessed by electro-acupuncture-based medicament testing.

The method is used to identify individual bioelectrical reactivity associated with the presence and persistence of pathological factors and to assess patient-specific responses to tested medicinal substances.

The study involves a single-session, non-invasive diagnostic procedure without administration of pharmacological treatment. The primary objective is the methodological evaluation of the diagnostic approach and the characterization of the detected bioelectrical response patterns in the studied population.

Full description

This study is a diagnostic clinical investigation designed to evaluate bioelectrical response patterns assessed by electro-acupuncture-based medicament testing.

The method is used to identify individual bioelectrical reactivity associated with the presence and persistence of pathological factors and to assess patient-specific responses to tested medicinal substances.

The study involves a single-session, non-invasive diagnostic procedure without pharmacological treatment. The primary objective is the methodological evaluation of the diagnostic approach and the characterization of the detected bioelectrical response patterns in the studied population.

Enrollment: 50 estimated patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 18 years or older
• History of confirmed SARS-CoV-2 infection
• Persistent symptoms consistent with Long COVID lasting ≥12 weeks after acute infection
• Ability to provide informed consent
• Willingness to undergo non-invasive bioelectrical diagnostic assessment

Exclusion criteria

• Acute infectious disease at the time of enrollment
• Severe uncontrolled medical or psychiatric conditions that may interfere with diagnostic assessment
• Implanted electronic medical devices (e.g., pacemaker)
• Pregnancy or breastfeeding
• Inability to comply with study procedures

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 1 patient group

Diagnostic Assesment Arm

Experimental group

Description:

This single-arm study includes participants undergoing a non-invasive electrodiagnostic assessment to evaluate bioelectrical response patterns associated with viral antigen persistence. No therapeutic intervention is administered.

Treatment:

Diagnostic Test: Electrodiagnostic Bioelectrical Assessment